<PAGE>
----------------------------
| OMB APPROVAL |
|----------------------------|
| OMB NUMBER: 3235-0145 |
| Expires: December 31, 1997 |
| Estimated average burden |
| hours per response...14.90 |
----------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. )*
---
BSD MEDICAL CORPORATION
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, $.01 PAR VALUE
- --------------------------------------------------------------------------------
(Title of Class of Securities)
055662100
---------------------------------------------------
(CUSIP Number)
c/o WILSON, BAKUTIS, JONES, SHELL, McCULLY & SAWYER, P.C.
DONALD P. WILSON, 500 THROCKMORTEN, SUITE 1100, FT. WORTH, TX 76102
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive
Notices and Communications)
NOVEMBER 13, 1996
-----------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [_].
Check the following box if a fee is being paid with the statement [_]. (A fee
is not required only if the reporting person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
NOTE: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Act of 1934
("Act") or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the Notes).
<PAGE>
SCHEDULE 13D
- ----------------------- ---------------------
CUSIP NO. 055662100 PAGE 1 OF 3 PAGES
- ----------------------- ---------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MRS. DORA LEE LANGDON SOCIAL SECURITY ####-##-####
P. O. BOX 278
GRANBURY, TX 76048-0278
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
(b) [X]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
SOURCE OF FUNDS*
4
PF
- ------------------------------------------------------------------------------
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e)
5 [_]
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
CITIZEN - UNITED STATES OF AMERICA
- ------------------------------------------------------------------------------
SOLE VOTING POWER
7
NUMBER OF
886,485 SHARES (5.5%)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8
0
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING 886,485 SHARES (5.5%)
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10
0
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11
886,485 SHARES (5.5%)
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
12 [_]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
5.5%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
14
IN
- ------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
<PAGE>
Schedule 13D
Reporting Person: Mrs. Dora Lee Langdon
P.O. Box 278
Granbury, TX 76048-0278
Social Security ####-##-####
Item 1. Security and Issuer:
-------------------
Common Stock, $.01 par value BSD MEDICAL CORPORATION
2188 West 2200 South
Salt Lake City, Utah 84119
Item 2. Identity and Background:
-----------------------
(a) Dora Lee Langdon
(b) P.O. Box 278
Granbury, TX 76048-0278
(c) Self-Employed; Investments, Charitable Pursuits
(d) No
(e) No
(f) United States of America
Item 3. Source and Amount of Funds or Other Consideration:
-------------------------------------------------
Personal Funds; Fifty Thousand and No/100 ($50,000.00)
Item 4. Purpose of Transaction:
----------------------
The purpose of the transaction is for investment purposes.
(a) No plans to acquire any additional securities of the issuer by
any person; no current plans to dispose of securities of the
issuer.
(b) None
(c) None
(d) None
<PAGE>
(e) None
(f) None
(g) None
(h) None
(i) None
(j) None
Item 5. Interest in Securities of the Issuer:
------------------------------------
(a) 886,485 shares in the aggregate; 5.5 percent of the class of
securities identified pursuant to Item 1.
(b) Dora Lee Langdon has the sole power to vote, and the sole power
to direct the disposition, of 886,485 shares.
(c) None, other than the purchase of 886,485 shares being reported
pursuant to this Schedule 13D.
(d) None
(e) Not applicable
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
---------------------------------------------------------------------
to Securities of the Issuer:
---------------------------
None
Item 7. None
Signature: After reasonable inquiry and to the best of my knowledge
and belief, I certify that the information set forth in this
statement is true, complete and correct.
----------------------- ------------------------------
Date Signature
Dora Lee Langdon, Owner
